Skip to main content
Top
Published in: BMC Neurology 1/2020

01-12-2020 | Alzheimer's Disease | Research article

Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study

Authors: Lirong Teng, Yongchao Li, Yu Zhao, Tao Hu, Zhe Zhang, Zhijun Yao, Bin Hu, Alzheimer’ s Disease Neuroimaging Initiative (ADNI)

Published in: BMC Neurology | Issue 1/2020

Login to get access

Abstract

Background

Mild cognitive impairment (MCI) is an intermediate stage between normal aging and dementia. Studies on MCI progression are important for Alzheimer’s disease (AD) prevention. 18F fluoro-deoxy-glucose positron emission tomography (FDG-PET) has been proven to be a powerful tool for measuring cerebral glucose metabolism. In this study, we proposed a classification framework for MCI prediction with both baseline and multiple follow-up FDG-PET scans as well as cognitive scores of 33 progressive MCI (pMCI) patients and 46 stable MCI (sMCI) patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Method

First, PET images were normalized using the Yakushev normalization procedure and registered to the Brainnetome Atlas (BNA). The average metabolic intensities of brain regions were defined as static features. Dynamic features were the intensity variation between baseline and the other three time points and change ratios with the intensity obtained at baseline considered as reference. Mini-mental State Examination (MMSE) scores and Alzheimer’s disease Assessment Scale-Cognitive section (ADAS-cog) scores of each time point were collected as cognitive features. And F-score was applied for feature selection. Finally, support vector machine (SVM) with radial basis function (RBF) kernel was used for the three above features.

Results

Dynamic features showed the best classification performance in accuracy of 88.61% than static features (accuracy of 78.48%). And the combination of cognitive features and dynamic features improved the classification performance in specificity of 95.65% and Area Under Curve (AUC) of 0.9308.

Conclusion

Our results reported that dynamic features are more representative in longitudinal research for MCI prediction work. And dynamic features and cognitive scores complementarily enhance the classification performance in specificity and AUC. These findings may predict the disease course and clinical changes in individuals with mild cognitive impairment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Winblad B, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455–532.CrossRef Winblad B, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455–532.CrossRef
2.
go back to reference Patterson C. World Alzheimer report 2018: the state of the art of dementia research: new frontiers. London: Alzheimer’s Disease International; 2018. Patterson C. World Alzheimer report 2018: the state of the art of dementia research: new frontiers. London: Alzheimer’s Disease International; 2018.
3.
go back to reference Brookmeyer R, et al. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3(3):186–91.CrossRef Brookmeyer R, et al. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3(3):186–91.CrossRef
4.
go back to reference Morris JC. And J.J.J.o.a.s.D. Cummings, Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. J Alzheimers Dis. 2005;7(3):235–9.CrossRef Morris JC. And J.J.J.o.a.s.D. Cummings, Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. J Alzheimers Dis. 2005;7(3):235–9.CrossRef
5.
go back to reference Galimberti D. And E.J.J.o.n. Scarpini, Progress in Alzheimer’s disease. J Neurol. 2012;259(2):201–11.CrossRef Galimberti D. And E.J.J.o.n. Scarpini, Progress in Alzheimer’s disease. J Neurol. 2012;259(2):201–11.CrossRef
6.
go back to reference Prince M, Bryce R, Ferri C. World Alzheimer Report 2011: The benefits of early diagnosis and intervention; 2018. Prince M, Bryce R, Ferri C. World Alzheimer Report 2011: The benefits of early diagnosis and intervention; 2018.
7.
go back to reference Veitch DP, et al. Understanding disease progression and improving Alzheimer's disease clinical trials: recent highlights from the Alzheimer's disease neuroimaging initiative. Alzheimers Dement. 2019;15(1):106–52.CrossRef Veitch DP, et al. Understanding disease progression and improving Alzheimer's disease clinical trials: recent highlights from the Alzheimer's disease neuroimaging initiative. Alzheimers Dement. 2019;15(1):106–52.CrossRef
8.
go back to reference Edmonds EC, et al. Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria. Neurology. 2016;87(20):2108–16.CrossRef Edmonds EC, et al. Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria. Neurology. 2016;87(20):2108–16.CrossRef
9.
go back to reference Palmqvist S, et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology. 2015;85(14):1240–9.CrossRef Palmqvist S, et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology. 2015;85(14):1240–9.CrossRef
10.
go back to reference Cerami C, et al. Brain metabolic maps in mild cognitive impairment predict heterogeneity of progression to dementia. Neuroimage Clin. 2015;7:187–94.CrossRef Cerami C, et al. Brain metabolic maps in mild cognitive impairment predict heterogeneity of progression to dementia. Neuroimage Clin. 2015;7:187–94.CrossRef
11.
go back to reference Toledo JB, et al. Metabolic network failures in Alzheimer's disease: a biochemical road map. Alzheimers Dement. 2017;13(9):965–84.CrossRef Toledo JB, et al. Metabolic network failures in Alzheimer's disease: a biochemical road map. Alzheimers Dement. 2017;13(9):965–84.CrossRef
12.
go back to reference Herholz K, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002;17(1):302–16.CrossRef Herholz K, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002;17(1):302–16.CrossRef
13.
go back to reference Chetelat G, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology. 2003;60(8):1374–7.CrossRef Chetelat G, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology. 2003;60(8):1374–7.CrossRef
14.
go back to reference Mosconi L, et al. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology. 2004;63(12):2332–40.CrossRef Mosconi L, et al. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology. 2004;63(12):2332–40.CrossRef
15.
go back to reference Ossenkoppele R, et al. Longitudinal imaging of Alzheimer pathology using [11 C] PIB,[18 F] FDDNP and [18 F] FDG PET. Eur J Nucl Med Mol Imaging. 2012;39(6):990–1000.CrossRef Ossenkoppele R, et al. Longitudinal imaging of Alzheimer pathology using [11 C] PIB,[18 F] FDDNP and [18 F] FDG PET. Eur J Nucl Med Mol Imaging. 2012;39(6):990–1000.CrossRef
16.
go back to reference Willette AA, et al. Prognostic classification of mild cognitive impairment and Alzheimer′ s disease: MRI independent component analysis. Psychiatry Res Neuroimaging. 2014;224(2):81–8.CrossRef Willette AA, et al. Prognostic classification of mild cognitive impairment and Alzheimer′ s disease: MRI independent component analysis. Psychiatry Res Neuroimaging. 2014;224(2):81–8.CrossRef
17.
go back to reference Li F, et al. A robust deep model for improved classification of AD/MCI patients. IEEE J Biomed Health Inform. 2015;19(5):1610–6.CrossRef Li F, et al. A robust deep model for improved classification of AD/MCI patients. IEEE J Biomed Health Inform. 2015;19(5):1610–6.CrossRef
18.
go back to reference Ma X, et al. Identify the atrophy of Alzheimer’s disease, mild cognitive impairment and normal aging using morphometric MRI analysis. Front Aging Neurosci. 2016;8:243.CrossRef Ma X, et al. Identify the atrophy of Alzheimer’s disease, mild cognitive impairment and normal aging using morphometric MRI analysis. Front Aging Neurosci. 2016;8:243.CrossRef
19.
go back to reference Thung K-H, et al. Identification of progressive mild cognitive impairment patients using incomplete longitudinal MRI scans. Brain Struct Funct. 2016;221(8):3979–95.CrossRef Thung K-H, et al. Identification of progressive mild cognitive impairment patients using incomplete longitudinal MRI scans. Brain Struct Funct. 2016;221(8):3979–95.CrossRef
20.
go back to reference Liu K, et al. Prediction of mild cognitive impairment conversion using a combination of independent component analysis and the cox model. Front Hum Neurosci. 2017;11:33.CrossRef Liu K, et al. Prediction of mild cognitive impairment conversion using a combination of independent component analysis and the cox model. Front Hum Neurosci. 2017;11:33.CrossRef
21.
go back to reference Davatzikos C, et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging. 2011;32(12):2322.e19–27.CrossRef Davatzikos C, et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging. 2011;32(12):2322.e19–27.CrossRef
22.
go back to reference Gray KR, et al. Random forest-based similarity measures for multi-modal classification of Alzheimer's disease. Neuroimage. 2013;65:167–75.CrossRef Gray KR, et al. Random forest-based similarity measures for multi-modal classification of Alzheimer's disease. Neuroimage. 2013;65:167–75.CrossRef
23.
go back to reference Popp J, et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Neurobiol Aging. 2015;36(2):601–7.CrossRef Popp J, et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Neurobiol Aging. 2015;36(2):601–7.CrossRef
24.
go back to reference Forlenza OV, et al. Cerebrospinal fluid biomarkers in Alzheimer's disease: diagnostic accuracy and prediction of dementia. Alzheimers Dement. 2015;1(4):455–63. Forlenza OV, et al. Cerebrospinal fluid biomarkers in Alzheimer's disease: diagnostic accuracy and prediction of dementia. Alzheimers Dement. 2015;1(4):455–63.
25.
go back to reference Cabral C, et al. Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages. Comput Biol Med. 2015;58:101–9.CrossRef Cabral C, et al. Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages. Comput Biol Med. 2015;58:101–9.CrossRef
26.
go back to reference Nozadi SH, Kadoury S, A.s.D.N. Initiative. Classification of Alzheimer’s and MCI patients from semantically parcelled PET images: a comparison between AV45 and FDG-PET. Int J Biomed imaging. 2018;2018:1247430.CrossRef Nozadi SH, Kadoury S, A.s.D.N. Initiative. Classification of Alzheimer’s and MCI patients from semantically parcelled PET images: a comparison between AV45 and FDG-PET. Int J Biomed imaging. 2018;2018:1247430.CrossRef
27.
go back to reference Pagani M, et al. Volume of interest-based [18F] fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's disease consortium (EADC) study. NeuroImage Clin. 2015;7:34–42.CrossRef Pagani M, et al. Volume of interest-based [18F] fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's disease consortium (EADC) study. NeuroImage Clin. 2015;7:34–42.CrossRef
28.
go back to reference Hinrichs C, et al. Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage. 2011;55(2):574–89.CrossRef Hinrichs C, et al. Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage. 2011;55(2):574–89.CrossRef
29.
go back to reference Ye J, et al. Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data. BMC Neurol. 2012;12(1):46.CrossRef Ye J, et al. Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data. BMC Neurol. 2012;12(1):46.CrossRef
30.
go back to reference Weiner MW, et al. The Alzheimer's disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement. 2013;9(5):e111–94.CrossRef Weiner MW, et al. The Alzheimer's disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement. 2013;9(5):e111–94.CrossRef
31.
go back to reference Gray KR, et al. Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease. Neuroimage. 2012;60(1):221–9.CrossRef Gray KR, et al. Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease. Neuroimage. 2012;60(1):221–9.CrossRef
32.
go back to reference Zhang D, Shen D, A.s.D.N.I.J.P. one. Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS One. 2012;7(3):e33182.CrossRef Zhang D, Shen D, A.s.D.N.I.J.P. one. Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS One. 2012;7(3):e33182.CrossRef
33.
go back to reference Rodrigues F, Silveira M. Longitudinal FDG-PET features for the classification of Alzheimer's disease. Proceedings of the 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2014. 2014(2014):1941–4. Rodrigues F, Silveira M. Longitudinal FDG-PET features for the classification of Alzheimer's disease. Proceedings of the 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2014. 2014(2014):1941–4.
34.
go back to reference Zhan Y, et al. Longitudinal study of impaired intra-and inter-network brain connectivity in subjects at high risk for Alzheimer’s disease. J Alzheimers Dis. 2016;52(3):913–27.CrossRef Zhan Y, et al. Longitudinal study of impaired intra-and inter-network brain connectivity in subjects at high risk for Alzheimer’s disease. J Alzheimers Dis. 2016;52(3):913–27.CrossRef
35.
go back to reference Fan L, et al. The human brainnetome atlas: a new brain atlas based on connectional architecture. Cereb Cortex. 2016;26(8):3508–26.CrossRef Fan L, et al. The human brainnetome atlas: a new brain atlas based on connectional architecture. Cereb Cortex. 2016;26(8):3508–26.CrossRef
36.
go back to reference Yakushev I, et al. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res Neuroimaging. 2008;164(2):143–53.CrossRef Yakushev I, et al. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res Neuroimaging. 2008;164(2):143–53.CrossRef
37.
go back to reference Yakushev I, et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage. 2009;44(1):43–50.CrossRef Yakushev I, et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage. 2009;44(1):43–50.CrossRef
38.
go back to reference Chen Y.-W, Lin C.-J. Combining SVMs with various feature selection strategies. Feature Extraction and Applications (Studies in Fuzziness and Soft Computing). Germany: Springer Berlin/Heidelberg. 2006. p. 315–24. Chen Y.-W, Lin C.-J. Combining SVMs with various feature selection strategies. Feature Extraction and Applications (Studies in Fuzziness and Soft Computing). Germany: Springer Berlin/Heidelberg. 2006. p. 315–24.
39.
go back to reference Fonti V, Belitser E. Feature selection using lasso. VU Amsterdam Research Paper in Business Analytics; 2017. p. 1–25. Fonti V, Belitser E. Feature selection using lasso. VU Amsterdam Research Paper in Business Analytics; 2017. p. 1–25.
40.
go back to reference Tax D, de Ridder D, Duin RP. Support vector classifiers: a first look. In: Proceedings ASCI; 1997. Tax D, de Ridder D, Duin RP. Support vector classifiers: a first look. In: Proceedings ASCI; 1997.
41.
go back to reference Vapnik V. SVM method of estimating density, conditional probability, and conditional density. In: 2000 IEEE International Symposium on Circuits and Systems. Emerging Technologies for the 21st Century. Proceedings (IEEE Cat No. 00CH36353). Chicago: IEEE. 2000;2:749–52. Vapnik V. SVM method of estimating density, conditional probability, and conditional density. In: 2000 IEEE International Symposium on Circuits and Systems. Emerging Technologies for the 21st Century. Proceedings (IEEE Cat No. 00CH36353). Chicago: IEEE. 2000;2:749–52.
42.
go back to reference Chang C-C, C.-J.J.A.t.o.i.s. Lin, and Technology. LIBSVM: a library for support vector machines. ACM Trans Intell Syst Technol. 2011;2(3):27.CrossRef Chang C-C, C.-J.J.A.t.o.i.s. Lin, and Technology. LIBSVM: a library for support vector machines. ACM Trans Intell Syst Technol. 2011;2(3):27.CrossRef
43.
go back to reference Hertz T, Hillel AB, Weinshall D. Learning a kernel function for classification with small training samples. Proceedings of the 23rd international conference on Machine learning, Pittsburgh, PA. 2006. p. 401–8. Hertz T, Hillel AB, Weinshall D. Learning a kernel function for classification with small training samples. Proceedings of the 23rd international conference on Machine learning, Pittsburgh, PA. 2006. p. 401–8.
44.
go back to reference Swets JAJS. Measuring the accuracy of diagnostic systems. Science. 1988;240(4857):1285–93. Swets JAJS. Measuring the accuracy of diagnostic systems. Science. 1988;240(4857):1285–93.
45.
go back to reference Bradley AP. The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recogn. 1997;30(7):1145–59. Bradley AP. The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recogn. 1997;30(7):1145–59.
46.
go back to reference Moradi E, et al. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects. Neuroimage. 2015;104:398–412. Moradi E, et al. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects. Neuroimage. 2015;104:398–412.
47.
go back to reference Xu L, et al. Multi-modality sparse representation-based classification for Alzheimer’s disease and mild cognitive impairment. Comput Methods Prog Biomed. 2015;122(2):182–90. Xu L, et al. Multi-modality sparse representation-based classification for Alzheimer’s disease and mild cognitive impairment. Comput Methods Prog Biomed. 2015;122(2):182–90.
48.
go back to reference Rocher AB, et al. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage. 2003;20(3):1894–8. Rocher AB, et al. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage. 2003;20(3):1894–8.
49.
go back to reference Zhang X, et al. Resting-state whole-brain functional connectivity networks for MCI classification using L2-regularized logistic regression. IEEE Trans Nanobiosci. 2015;14(2):237–47. Zhang X, et al. Resting-state whole-brain functional connectivity networks for MCI classification using L2-regularized logistic regression. IEEE Trans Nanobiosci. 2015;14(2):237–47.
50.
go back to reference Wang W-Y, et al. Impacts of CD33 genetic variations on the atrophy rates of hippocampus and parahippocampal gyrus in normal aging and mild cognitive impairment. Mol Neurobiol. 2017;54(2):1111–8. Wang W-Y, et al. Impacts of CD33 genetic variations on the atrophy rates of hippocampus and parahippocampal gyrus in normal aging and mild cognitive impairment. Mol Neurobiol. 2017;54(2):1111–8.
51.
go back to reference Lin F, et al. Insula and inferior frontal gyrus’ activities protect memory performance against Alzheimer’s disease pathology in old age. J Alzheimers Dis. 2017;55(2):669–78. Lin F, et al. Insula and inferior frontal gyrus’ activities protect memory performance against Alzheimer’s disease pathology in old age. J Alzheimers Dis. 2017;55(2):669–78.
52.
go back to reference Cui Y, et al. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One. 2011;6(7):e21896. Cui Y, et al. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One. 2011;6(7):e21896.
53.
go back to reference Wang P, et al. Multimodal classification of mild cognitive impairment based on partial least squares. J Alzheimers Dis. 2016;54(1):359–71. Wang P, et al. Multimodal classification of mild cognitive impairment based on partial least squares. J Alzheimers Dis. 2016;54(1):359–71.
Metadata
Title
Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study
Authors
Lirong Teng
Yongchao Li
Yu Zhao
Tao Hu
Zhe Zhang
Zhijun Yao
Bin Hu
Alzheimer’ s Disease Neuroimaging Initiative (ADNI)
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2020
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-020-01728-x

Other articles of this Issue 1/2020

BMC Neurology 1/2020 Go to the issue